Smooth Muscle and Endothelial Cells as Pharmacological Targets for Acute Oxidative Stress

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".

Deadline for manuscript submissions: 25 July 2024 | Viewed by 242

Special Issue Editor

E-Mail Website
Guest Editor
Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA
Interests: pulmonary hypertension; apoptosis; microcirculation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Reactive oxygen species (ROS) play an important role in physiological cell signaling. However, excessive levels of ROS damage cells. Acute oxidative stress results from ischemia reperfusion injuries such as stroke, myocardial infarction, and vascular occlusion during surgery in addition to acute injuries such as traumatic brain injury. While great attention has been devoted to limiting damage from acute oxidative stress on the surrounding tissue, the development of strategies to limit smooth muscle and endothelial cell damage to maintain perfusion to the effected tissue is emerging as a promising therapeutic focus.

Damage to smooth muscle and endothelial cells can impair vasomotor control and result in cell death. Recent efforts have begun to evaluate how to ameliorate this damage. In this Special Issue, we seek to bring together research from experts in the field to highlight pharmacological targets to limit vascular cell damage in response to acute oxidative stress. I look forward to receiving your valuable contributions.

Dr. Charles E. Norton
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • reactive oxygen species
  • oxidative stress
  • smooth muscle cells
  • endothelium
  • ischemia/reperfusion
  • stroke
  • myocardial infarction
  • traumatic brain injury

Published Papers

This special issue is now open for submission.
Back to TopTop